Cargando…
Development of a Novel Enzyme-Targeting Radiosensitizer (New KORTUC) Using a Gelatin-Based Hydrogel Instead of a Sodium Hyaluronate
We recently developed Kochi Oxydol-Radiation Therapy for Unresectable Carcinomas (KORTUC) as a strategy to increase intratumoral oxygen concentrations and degrade antioxidant enzymes such as peroxidase and catalase. We then developed KORTUC II, which uses sodium hyaluronate containing hydrogen perox...
Autores principales: | Morita-Tokuhiro, Shiho, Ogawa, Yasuhiro, Yokota, Norikazu, Tsuzuki, Akira, Oda, Hideki, Ishida, Naoya, Aoyama, Nobutaka, Nishioka, Akihito |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728457/ https://www.ncbi.nlm.nih.gov/pubmed/26751477 http://dx.doi.org/10.3390/cancers8010010 |
Ejemplares similares
-
Computed Tomography Demonstration of the Production and Distribution of Oxygen Gas Following Intratumoral Injection of a New Radiosensitizer (KORTUC) for Patients with Breast Cancer—Is Intratumoral Injection Not an Ideal Approach to Solve the Major Problem of Tumor Hypoxia in Radiotherapy?
por: Hayashi, Naoya, et al.
Publicado: (2016) -
Non-Surgical Breast-Conserving Treatment (KORTUC-BCT) Using a New Radiosensitization Method (KORTUC II) for Patients with Stage I or II Breast Cancer
por: Ogawa, Yasuhiro, et al.
Publicado: (2015) -
Serial Assessment of Therapeutic Response to a New Radiosensitization Treatment, Kochi Oxydol-Radiation Therapy for Unresectable Carcinomas, Type II (KORTUC II), in Patients with Stage I/II Breast Cancer Using Breast Contrast-Enhanced Magnetic Resonance Imaging
por: Yaogawa, Shin, et al.
Publicado: (2015) -
Evaluation of Changes in Tumor Shadows and Microcalcifications on Mammography Following KORTUC II, a New Radiosensitization Treatment without any Surgical Procedure for Elderly Patients with Stage I and II Breast Cancer
por: Tsuzuki, Akira, et al.
Publicado: (2011) -
New enzyme-targeting radiosensitizer (KORTUC II) treatment for locally advanced or recurrent breast cancer
por: Shimbo, Taiju, et al.
Publicado: (2021)